Search Results - "Zipursky, A"

GATA1 mutations as clonal markers of minimal residual disease in acute megakaryoblastic leukemia of Down syndrome—a new tool with significant potential applications by Hitzler, J., Zipursky, A.

Get full text

Erythropoietin therapy for premature infants : Cost without benefit? by ZIPURSKY, A

Get full text

The Programme for Global Paediatric Research by Manley, M, Zipursky, A

“…Millions of children die every year from malaria, tuberculosis, diarrhoea, neonatal disorders, and many other diseases found primarily in low and mid income…”
Get full text

Distinct gene signatures of transient and acute megakaryoblastic leukemia in Down syndrome by LIGHTFOOT, J, HITZLER, J. K, ZIPURSKY, A, ALBERT, M, MACGREGOR, P. F

“…Approximately 10% of newborns with Down syndrome develop Transient Leukemia (TL), a disorder that is unique to infants with constitutional trisomy 21 (or…”
Get full text

Susceptibility to leukemia and resistance to solid tumors in Down syndrome by Zipursky, A

Get full text

Fetal origin of leukemia and autologous cord blood transfusions by Zipursky, A

Get full text

A new european editorial office by Zipursky, A

Get full text

Transient leukaemia – a benign form of leukaemia in newborn infants with trisomy 21 by Zipursky, Alvin

Get full text

Telomerase, immortality, and cancer by Zipursky, A

Get full text

Leukemia and/or myeloproliferative syndrome in neonates with Down Syndrome by Zipursky, Alvin, Brown, Elizabeth, Christensen, Hilary, Sutherland, Robert, Doyle, John

“…Approximately 10% of newborn infants with Down Syndrome develop a form of megakaryoblastic leukemia which usually disappears spontaneously during the first…”
Get full text

Ethics and responsibilities in pediatric research by Zipursky, A

Get full text

Short-course oral prednisone therapy in children presenting with acute immune thrombocytopenic purpura (ITP) by Carcao, MD, Zipursky, A, Butchart, S, Leaker, M, Blanchette, VS

“…Immune thrombocytopenic purpura (ITP) is a disorder for which management remains controversial. The ongoing goal is to define the minimal therapy required for…”
Get full text

Myelodysplasia and acute megakaryoblastic leukemia in Down's syndrome by Zipursky, A, Thorner, P, De Harven, E, Christensen, H, Doyle, J

“…In this report we describe the clinical and hematologic features of 23 cases of myelodysplasia (MDS) or acute megakaryoblastic leukemia (AMKL) occurring in…”
Get more information

Transient myeloproliferative disorder (transient leukemia) and hematologic manifestations of Down syndrome by Zipursky, A, Brown, E J, Christensen, H, Doyle, J

“…Transient Myeloproliferative Disorder (Transient Leukemia) is found in approximately 10% of newborn infants with Down Syndrome. It is characterized by the…”
Get more information

A new variant translocation in acute promyelocytic leukaemia: molecular characterization and clinical correlation by Wells, R A, Hummel, J L, De Koven, A, Zipursky, A, Kirby, M, Dubé, I, Kamel-Reid, S

“…Translocation t(15;17)(q22;q21) is an acquired clonal cytogenetic change present in almost all cases of acute promelocytic leukemia (APL). The molecular…”
Get more information

Pediatric Research Looks to the Future by Zipursky, Alvin, Lagercrantz, Hugo

Get full text

Origins of leukaemia in children with Down syndrome by Hitzler, Johann K, Zipursky, Alvin

“…Transient megakaryoblastic leukaemia is found in 10% of newborns with Down syndrome, characterized by constitutional trisomy 21. Although in most cases the…”
Get full text

Cytogenetic and molecular studies of down syndrome individuals with leukemia by SHEN, J. J, WILLIAMS, B. J, ZIPURSKY, A, DOYLE, J, SHERMAN, S. L, JACOBS, P. A, SHUGAR, A. L, SOUKUP, S. W, HASSOLD, T. J

“…There is an increased risk of leukemia in Down syndrome (DS) patients, with estimates ranging from 14 to 30 times the incidence rate observed for chromosomally…”
Get full text

The global burden of Rh disease by Zipursky, Alvin, Paul, Vinod K

Get more information

Vitamin K at birth by Zipursky, Alvin

“…Clearly, the question over the risks of intramuscular vitamin K needed resolving. Since 1992 several studies have suggested that vitamin K was not associated…”
Get full text